The Korea National Institute of Health said that it will publicly share its multi-omics data, clinical data, and human biobank samples from COVID-19 patients.
Multiomics refers to integrated data produced to genetically, functionally, and environmentally understand the collection of particles and cells from human biobank samples.
The institute said that it has acquired clinical data and biobank samples from 300 COVID-19 patients and 120 non-COVID-19 patients through ethical and legal agreement procedures.
Click here to read more.